Global Epidemiology: Evolving Threats, New Tools

Helena Fischer

Introduction

Genomic sequencing is revolutionizing our understanding of emerging infectious disease epidemiology, providing sophisticated tools for enhanced surveillance, thorough outbreak investigation, and precise tracking of pathogen evolution [1].

However, the effective integration of vast genomic datasets for timely public health decisions and policy-making presents considerable challenges that demand careful attention. A comprehensive global epidemiological overview of influenza between 2000 and 2021 meticulously details its incidence, prevalence, and mortality across diverse age groups and geographical regions [2].

This analysis emphasizes the continuous and dynamic public health threat posed by both seasonal and pandemic influenza strains worldwide, necessitating ongoing vigilance. Examining the evolving epidemiological landscape of tuberculosis and drug-resistant tuberculosis in the Western Pacific Region from 2010 to 2021 reveals critical trends [3].

This systematic review and meta-analysis identifies high-burden areas and factors contributing to drug resistance, highlighting the persistent and significant challenges in regional TB control efforts. The global distribution and epidemiological trends of various tick-borne diseases are showing increasing incidence and geographical spread [4].

These changes are often attributed to critical factors such as climate change, ecological shifts, and human activities. This growing threat underscores an urgent need for enhanced surveillance and comprehensive prevention strategies globally. Updated global estimates for 2020 shed light on the prevalence and incidence of four major curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and trichomoniasis [5].

The findings from this extensive review confirm a significant and persistent public health burden, reinforcing the continuous necessity for robust prevention and control programs globally to address these widespread infections. An updated global overview of the epidemiology of invasive fungal infections reveals significant changes [6].

It meticulously details shifts in incidence, the expanding spectrum of causative pathogens, and the populations most at risk. This highlights their increasing clinical significance and the persistent difficulties encountered in both their timely diagnosis and effective treatment worldwide. Community-acquired infections are increasingly challenged by global epidemiological trends of antibiotic resistance [7].

This research identifies key resistant pathogens and significant geographical variations in resistance patterns. This situation urgently calls for enhanced surveillance, more prudent antibiotic use, and the development of novel therapeutic strategies to combat this growing worldwide threat to public health. A comprehensive overview of diarrhoeal diseases in sub-Saharan Africa quantifies their incidence, prevalence, and mortality across various age groups [8].

This systematic review and meta-analysis also identifies crucial risk factors and prevalent pathogens, underscoring the persistent and significant public health challenge these diseases continue to pose in the region. A systematic analysis from 1990 to 2019 offers a comprehensive global perspective on norovirus gastroenteritis [9].

It details trends in incidence, prevalence, and mortality across different age groups and regions. This highlights its significant burden, particularly in vulnerable populations such as young children and older adults, and its ongoing impact on public health worldwide. The epidemiology and burden of malaria in sub-Saharan Africa is meticulously analyzed in an updated systematic review and meta-analysis [10].

This work focuses on trends in incidence, prevalence, and mortality, while also identifying key challenges and successes in ongoing control efforts, thereby illustrating the region's disproportionate and persistent burden of the disease.

Description

Recent advancements in genomic sequencing are profoundly transforming our understanding of emerging infectious diseases [1]. These advancements offer powerful new tools for surveillance, detailed outbreak investigation, and precise tracking of pathogen evolution. The challenge remains in effectively integrating this vast genomic data to inform timely public health decisions and policy-making. Concurrently, a systematic review covering 2000 to 2021 provides a global epidemiological overview of influenza, detailing its incidence, prevalence, and mortality across various age groups and regions [2]. This highlights the continuous and dynamic public health threat posed by both seasonal and pandemic influenza strains worldwide.

The epidemiological landscape of tuberculosis and its drug-resistant forms in the Western Pacific Region between 2010 and 2021 has undergone significant changes [3]. Analysis identifies key trends, high-burden areas, and factors contributing to drug resistance, which underlines the ongoing difficulties in regional TB control efforts. Separately, a global examination of tick-borne diseases reveals an increasing incidence and geographical spread [4]. These trends are frequently linked to climate change, ecological shifts, and human activities, emphasizing the urgent need for enhanced surveillance and comprehensive prevention strategies globally.

Updated global estimates for 2020 shed light on the prevalence and incidence of four major curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and trichomoniasis [5]. The findings from this extensive review confirm a significant and persistent public health burden, stressing the continuous need for robust prevention and control programs worldwide. Furthermore, a global overview of invasive fungal infections outlines significant changes in incidence, the spectrum of causative pathogens, and at-risk populations [6]. This underscores their increasing clinical significance and the persistent challenges in their timely diagnosis and effective treatment.

Community-acquired infections are increasingly challenged by global epidemiological trends of antibiotic resistance [7]. This research identifies key resistant pathogens and significant geographical variations in resistance patterns. This situation urgently calls for enhanced surveillance, more prudent antibiotic use, and the development of novel therapeutic strategies to combat this growing worldwide threat. In sub-Saharan Africa, diarrhoeal diseases continue to pose a significant public health challenge [8]. A detailed review quantifies their incidence, prevalence, and mortality across various age groups, also pinpointing key risk factors and prevalent pathogens in the region.

From 1990 to 2019, a systematic analysis offers a comprehensive global perspective on norovirus gastroenteritis [9]. It highlights trends in incidence, prevalence, and mortality across different age groups and regions, emphasizing its substantial burden, especially in vulnerable populations such as young children and older adults, and its ongoing global public health impact. Finally, the epidemiology and burden of malaria in sub-Saharan Africa remain a critical focus [10]. An updated review meticulously analyzes trends in incidence, prevalence, and mortality, while also identifying key challenges and successes in ongoing control efforts, thereby illustrating the region's disproportionate and persistent burden of the disease.

Conclusion

Recent research highlights the dynamic and persistent challenges in global public health epidemiology. Genomic sequencing is profoundly transforming our understanding of emerging infectious diseases, providing novel tools for surveillance and pathogen tracking, though its effective integration for timely public health decisions remains a hurdle. Studies on influenza and norovirus gastroenteritis reveal continuous global threats, detailing incidence, prevalence, and mortality across diverse populations and regions. These analyses underscore the significant burden these viral infections place, particularly on vulnerable groups like young children and older adults. Moreover, regional disease patterns present specific concerns. Tuberculosis and drug-resistant forms in the Western Pacific Region continue to show evolving trends and high-burden areas, necessitating sustained control efforts. In sub-Saharan Africa, both diarrhoeal diseases and malaria represent persistent and disproportionate public health challenges, with research quantifying their impact and identifying critical risk factors and control successes. Globally, other infectious threats are also expanding. Tick-borne diseases are increasing in incidence and geographical spread, often attributed to climate change and ecological shifts, which calls for enhanced surveillance and prevention. Curable sexually transmitted infections such as chlamydia, gonorrhoea, syphilis, and trichomoniasis still constitute a substantial global burden, emphasizing the ongoing need for robust prevention programs. A growing worldwide concern is antibiotic resistance in community-acquired infections, where studies identify resistant pathogens and geographical variations, urging for more prudent antibiotic use and innovative therapeutic strategies. Lastly, invasive fungal infections are gaining clinical significance, showing changes in incidence, pathogen spectrum, and at-risk populations, coupled with persistent diagnostic and treatment challenges. These findings collectively paint a picture of complex and evolving epidemiological landscapes worldwide, demanding continuous research and coordinated public health interventions.

Acknowledgement

None

Conflict of Interest

None

References

Marc L, Mike H, Christophe F. "The epidemiology of emerging infectious diseases in the genomics era: challenges and opportunities".Lancet Infect Dis 23 (2023):e51-e58.

Indexed at, Google Scholar, Crossref

Yixin X, Jun C, Chao T. "Global Epidemiology of Influenza: A Systematic Review and Meta-Analysis of Studies from 2000 to 2021".Emerg Microbes Infect 11 (2022):159-173.

Indexed at, Google Scholar, Crossref

Ha TP, Du TN, D. THH. "Tuberculosis epidemiology and drug resistance in Western Pacific Region, 2010-2021: a systematic review and meta-analysis".Sci Rep 13 (2023):13524.

Indexed at, Google Scholar, Crossref

Han M, Di L, Haiyin M. "The global epidemiology of tick-borne diseases: A systematic review".Front Public Health 10 (2022):1062973.

Indexed at, Google Scholar, Crossref

Justine R, J. JO, Lut VD. "Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2020: an updated systematic review and meta-analysis".Lancet Glob Health 10 (2022):e1797-e1809.

Indexed at, Google Scholar, Crossref

Andrew HL, Sujal K, Jeffrey K. "Epidemiology of invasive fungal infections: a global perspective".Lancet Infect Dis 23 (2023):e258-e269.

Indexed at, Google Scholar, Crossref

Alessandro C, C. C, Anna PP. "Epidemiology of antibiotic resistance in community-acquired infections: a global perspective".Future Microbiol 17 (2022):421-434.

Indexed at, Google Scholar, Crossref

Ellis O, Edward A, George DA. "Epidemiology of diarrhoeal diseases in sub-Saharan Africa: a systematic review and meta-analysis".BMC Public Health 21 (2021):1930.

Indexed at, Google Scholar, Crossref

Han M, Xinyu S, Yi L. "Global, regional, and national incidence, prevalence, and deaths of norovirus gastroenteritis: A systematic analysis from 1990 to 2019".Front Public Health 10 (2022):1010372.

Indexed at, Google Scholar, Crossref

M. MN, G. RAO, P. U. "Epidemiology and burden of malaria in sub-Saharan Africa: a systematic review and meta-analysis".Infect Dis Poverty 12 (2023):79.

Indexed at, Google Scholar, Crossref